Nektar Therapeutics (NKTR)
(Delayed Data from NSDQ)
$1.24 USD
-0.08 (-6.06%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $1.25 +0.01 (0.81%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.20 | -8.64% |
Earnings Summary
For their last quarter, Nektar Therapeutics (NKTR) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.20 per share. This reflects a negative earnings surprise of 10.00%. Look out for NKTR's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for NKTR
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
NKTR: What are Zacks experts saying now?
Zacks Private Portfolio Services